acadesine: Clinical Trials

3 trials of acadesine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 2 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Terminated 1
Phase 31Terminated 1

Follow acadesine: new trials by email Literature Review of acadesine trials Research Report on acadesine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GFM-Acadesine: A Phase I-II Trial of Acadesine
ACADESINE 140mg/kg/d, ACADESINE 210mg/kg/d, ACADESINE 315mg/kg/d - SMD
Phase 1 / Phase 2TerminatedGroupe Francophone des Myelodysplasies52013-06-012016-11-08
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
Acadesine, Normal Saline - Coronary Artery Bypass, Myocardial Infarction
Phase 3TerminatedMerck Sharp & Dohme LLC30802009-04-012015-10-29
Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
Acadesine - Leukemia, B-Cell, Chronic
Phase 1 / Phase 2CompletedAdvancell - Advanced In Vitro Cell Technologies, S.A.402007-12-012011-05-10

Conditions studied

Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Myocardial Infarction (1)  ·  Stroke (1)  ·  Ventricular Dysfunction, Left (1)

Sponsors

Advancell - Advanced In Vitro Cell Technologies, S.A. (1)  ·  Groupe Francophone des Myelodysplasies (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

France (2)  ·  Belgium (1)  ·  Spain (1)

Top investigators

Eric Van Den Neste, MD (1)  ·  Pierre Fenaux, MD (1)  ·  Thomas Cluzeau, MD (1)

Results publications

PMID 22782417, PMID 25218533